Parametric Portfolio Associates’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $3.23M | Buy |
198,832
+70,189
| +55% | +$1.14M | ﹤0.01% | 2138 |
|
|
2021
Q4 | $1.78M | Sell |
128,643
-100,413
| -44% | -$1.39M | ﹤0.01% | 2503 |
|
|
2021
Q3 | $3.29M | Buy |
229,056
+9,042
| +4% | +$130K | ﹤0.01% | 2123 |
|
|
2021
Q2 | $3.48M | Buy |
220,014
+118,825
| +117% | +$1.88M | ﹤0.01% | 2108 |
|
|
2021
Q1 | $1.03M | Buy |
101,189
+16,655
| +20% | +$169K | ﹤0.01% | 3154 |
|
|
2020
Q4 | $630K | Buy |
84,534
+189
| +0.2% | +$1.41K | ﹤0.01% | 3273 |
|
|
2020
Q3 | $290K | Sell |
84,345
-457,784
| -84% | -$1.57M | ﹤0.01% | 3499 |
|
|
2020
Q2 | $2.58M | Buy |
542,129
+492,761
| +998% | +$2.35M | ﹤0.01% | 2335 |
|
|
2020
Q1 | $99K | Buy |
49,368
+17,849
| +57% | +$35.8K | ﹤0.01% | 3733 |
|
|
2019
Q4 | $109K | Sell |
31,519
-25,099
| -44% | -$86.8K | ﹤0.01% | 3850 |
|
|
2019
Q3 | $162K | Buy |
56,618
+39,963
| +240% | +$114K | ﹤0.01% | 3756 |
|
|
2019
Q2 | $63K | Sell |
16,655
-112,651
| -87% | -$426K | ﹤0.01% | 3893 |
|
|
2019
Q1 | $1.05M | Buy |
129,306
+13,196
| +11% | +$107K | ﹤0.01% | 3004 |
|
|
2018
Q4 | $937K | Buy |
+116,110
| New | +$937K | ﹤0.01% | 3020 |
|
|
2018
Q3 | – | Sell |
-14,284
| Closed | -$82K | – | 3939 |
|
|
2018
Q2 | $82K | Buy |
14,284
+1,407
| +11% | +$8.08K | ﹤0.01% | 3821 |
|
|
2018
Q1 | $61K | Buy |
12,877
+1,157
| +10% | +$5.48K | ﹤0.01% | 3894 |
|
|
2017
Q4 | $58K | Buy |
11,720
+648
| +6% | +$3.21K | ﹤0.01% | 3858 |
|
|
2017
Q3 | $58K | Buy |
+11,072
| New | +$58K | ﹤0.01% | 3985 |
|
|
2014
Q4 | – | Sell |
-14,960
| Closed | -$146K | – | 3982 |
|
|
2014
Q3 | $146K | Buy |
+14,960
| New | +$146K | ﹤0.01% | 3676 |
|